Total Payments
$2,428
2024 Payments
$160.47
Companies
17
Transactions
85
Medicare Patients
2,002
Medicare Billing
$70,558
Payment Breakdown by Category
Food & Beverage$2,428 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,428 | 85 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $754.12 | 34 | $0 (2024) |
| ITI, Inc. | $391.62 | 9 | $0 (2023) |
| Amgen Inc. | $196.87 | 5 | $0 (2023) |
| Novo Nordisk Inc | $146.95 | 2 | $0 (2023) |
| Dexcom, Inc. | $144.01 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $142.64 | 8 | $0 (2023) |
| Eisai Inc. | $123.17 | 2 | $0 (2023) |
| Allergan, Inc. | $117.09 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $100.48 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $66.90 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $160.47 | 2 | Dexcom, Inc. ($144.01) |
| 2023 | $1,337 | 51 | ABBVIE INC. ($472.34) |
| 2022 | $931.45 | 32 | ABBVIE INC. ($265.32) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $144.01 | General |
| Category: Endocrinology | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 10/19/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: Neurology | ||||||
| 10/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $105.47 | General |
| Category: Neurology | ||||||
| 09/20/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: VACCINES | ||||||
| 09/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/29/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/28/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/05/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,376 | 1,480 | $220,245 | $43,442 |
| 2022 | 14 | 626 | 670 | $108,130 | $27,115 |
Total Patients
2,002
Total Services
2,150
Medicare Billing
$70,558
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 191 | $74,680 | $16,207 | 21.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 63 | 63 | $38,745 | $7,978 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 112 | $34,460 | $7,809 | 22.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 178 | 196 | $29,895 | $1,904 | 6.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 124 | 125 | $7,785 | $1,615 | 20.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 166 | 189 | $6,015 | $1,579 | 26.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 140 | 145 | $6,305 | $1,481 | 23.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 27 | $5,490 | $1,215 | 22.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 125 | 130 | $4,340 | $984.15 | 22.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 43 | 44 | $3,270 | $724.24 | 22.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 33 | 33 | $2,805 | $576.64 | 20.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 42 | 43 | $1,910 | $380.12 | 19.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 11 | 11 | $1,205 | $319.11 | 26.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 31 | 31 | $1,410 | $293.21 | 20.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 110 | 112 | $980.00 | $239.96 | 24.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 13 | $825.00 | $122.54 | 14.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 15 | $125.00 | $14.00 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 96 | $36,480 | $9,510 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 96 | $24,960 | $7,465 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 36 | 36 | $22,140 | $4,677 | 21.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $3,945 | $1,371 | 34.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 75 | 79 | $9,300 | $891.47 | 9.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $1,900 | $705.80 | 37.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 58 | 59 | $2,135 | $601.84 | 28.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 46 | 46 | $2,190 | $592.13 | 27.0% |
About Tania Chery, DNP, FNP-BC
Tania Chery, DNP, FNP-BC is a Family healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2021. The National Provider Identifier (NPI) number assigned to this provider is 1326705161.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tania Chery, DNP, FNP-BC has received a total of $2,428 in payments from pharmaceutical and medical device companies, with $160.47 received in 2024. These payments were reported across 85 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,428).
As a Medicare-enrolled provider, Chery has provided services to 2,002 Medicare beneficiaries, totaling 2,150 services with total Medicare billing of $70,558. Data is available for 2 years (2022–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Manhasset, NY
- Active Since 11/29/2021
- Last Updated 06/28/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326705161
Products in Payments
- CAPLYTA (Drug) $391.62
- VRAYLAR (Drug) $345.13
- UBRELVY (Drug) $211.09
- QULIPTA (Drug) $197.90
- Repatha (Biological) $196.87
- Ozempic (Drug) $146.95
- DEXCOM G7 GSS (161) (Medical Supply) $144.01
- VERQUVO (Drug) $125.82
- Leqembi (Drug) $123.17
- FARXIGA (Drug) $100.48
- XARELTO (Drug) $66.90
- ENTRESTO (Drug) $50.11
- Inpefa (Drug) $41.81
- JARDIANCE (Drug) $32.55
- Livalo (Drug) $31.30
- LIVALO (Drug) $29.85
- TRELEGY ELLIPTA (Drug) $24.19
- LifeVest (Device) $19.97
- BELSOMRA (Drug) $16.82
- PREVNAR 20 (Biological) $14.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Manhasset
Catherine Pham, Np, NP
Family — Payments: $5,773
Family $5,773
Mrs. Bessy Thangavelu, Fnp, FNP
Family — Payments: $2,120
Family $2,120
Mrs. Amanda Colandro, Fnp, FNP
Family — Payments: $1,964
Family $1,964
Marsha Mcgee, Fnp, FNP
Family — Payments: $1,728
Family $1,728
Melodie Lin, Fnp-Bc, FNP-BC
Family — Payments: $1,589
Family $1,589
Ellen Buck, Np, NP
Family — Payments: $1,506
Family $1,506